Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
948,076
-
Share change
-
-52,517
-
Total reported value
-
$2,228,639
-
Price per share
-
$2.38
-
Number of holders
-
23
-
Value change
-
-$143,072
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q3 2024
As of 30 Sep 2024,
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
948,076 shares.
The largest 10 holders included
LEVIN CAPITAL STRATEGIES, L.P., HighTower Advisors, LLC, SATOVSKY ASSET MANAGEMENT LLC, Private Advisor Group, LLC, MORGAN STANLEY, Mariner, LLC, GEODE CAPITAL MANAGEMENT, LLC, Kovitz Investment Group Partners, LLC, NORTHERN TRUST CORP, and Financial Guidance Group, Inc..
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.